Tokiwa T, Sato J
Gan. 1976 Dec;67(6):879-83.
Liver tissue cells derived from rats fed 4-(dimethylamino)azobenzene (DAB) were maintained in vitro for several months. These cells showed higher malignancy after treatment with 4.8 or 19.2 mug/ml of DAB. Subcutaneous back-transplantation of DAB-treated cells showed an earlier appearance of palpable tumors and a higher rate of "take" than the non-treated control cells. The tumor size at 60 days after back-transplantation was also significantly larger in the DAB-treated cells. Long-term treatment with DAB produced few morphological changes of the cells in vitro, but the plating efficiency and resistance to toxic effects of DAB were significantly higher in the treated cells than in the control cells. On the other hand, no definite differences in chromosome number were found between the treated and control cells. These findings suggested that cell malignancy could be promoted by long-term treatment with DAB in vitro
用4-(二甲基氨基)偶氮苯(DAB)喂养的大鼠来源的肝组织细胞在体外维持了数月。用4.8或19.2微克/毫升的DAB处理后,这些细胞显示出更高的恶性程度。皮下回植经DAB处理的细胞比未处理的对照细胞更早出现可触及的肿瘤,且“移植成功”率更高。回植后60天,经DAB处理的细胞的肿瘤大小也明显更大。长期用DAB处理在体外几乎未引起细胞形态变化,但处理后的细胞的接种效率和对DAB毒性作用的抗性明显高于对照细胞。另一方面,处理后的细胞与对照细胞之间在染色体数目上未发现明确差异。这些发现表明,长期在体外用DAB处理可促进细胞恶性化。